Knott David M Jr
- SEC CIK
- 0001892770
- Latest filing
- Aug 12, 2026
VKTX holding history
Viking Therapeutics, Inc. in every 13F filed by Knott David M Jr, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VKTX overviewAll 13F holders of VKTXFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −39,036−100.0% | Sold out | Holders |
| Q4 2024 | 39,036 | $1.57M | 0.6% | 00.0% | Unchanged | Holders |
| Q3 2024 | 39,036 | $2.47M | 1.0% | −37,000−48.7% | Reduced | Holders |
| Q2 2024 | 76,036 | $4.03M | 1.6% | −25,400−25.0% | Reduced | Holders |
| Q1 2024 | 101,436 | $8.32M | 2.9% | −169,386−62.5% | Reduced | Holders |
| Q4 2023 | 270,822 | $5.04M | 1.9% | +85,267+46.0% | Added | Holders |
| Q3 2023 | 185,555 | $2.05M | 0.8% | +110,006+145.6% | Added | Holders |
| Q2 2023 | 75,549 | $1.23M | 0.5% | −124,615−62.3% | Reduced | Holders |
| Q1 2023 | 200,164 | $3.33M | 1.4% | −181,457−47.5% | Reduced | Holders |
| Q4 2022 | 381,621 | $3.59M | 1.6% | +79,818+26.4% | Added | Holders |
| Q3 2022 | 301,803 | $821.0K | 0.4% | +35,000+13.1% | Added | Holders |
| Q2 2022 | 266,803 | $771.0K | 0.4% | +38,701+17.0% | Added | Holders |
| Q1 2022 | 228,102 | $684.0K | 0.2% | +20,000+9.6% | Added | Holders |
| Q4 2021 | 208,102 | $957.0K | 0.4% | – | No prior filing | Holders |